China’s first-ever futures for lithium — an essential ingredient for electric vehicle batteries — got off to a

If you're in need of a streaming music service, and you already have an Amazon

By Mike Scarcella A U.S. judge on Thursday approved Apple Inc's $50 million class-action settlement resolving consumer claims

By Kanishka Singh WASHINGTON A U.S. judge on Thursday dismissed a lawsuit against Alphabet Inc's Google that was

STAMFORD, Conn.--(BUSINESS WIRE)--Aug 10, 2023--

Elon Musk's chip implant company Neuralink is looking for its first volunteer since the company got approved to perform tests on humans by the FDA. Prior to its approval for human clinical trials, Reuters reported that the company had killed roughly 1,500 animals during testing. The volunteer would have to be willing to have a piece of their skull removed so a robotic surgeon can insert thin wires and electrodes into their brain. The company told Bloomberg News, the ideal candidate will be a quadriplegic under the age of 40. Neuralink hopes to eventually make a device that will allow people to send messages or play games using only their thoughts. Ashlee Vance, the author of the 2015 biography 'Elon Musk: Tesla, SpaceX, and the Quest for a Fantastic Future', said in his Bloomberg report that despite "an outpouring of interest from thousands of prospective patients," the company is still seeking its first volunteer. The chip would enable computer functions to be performed using only thoughts via a "think-and-click" mechanism. If the ideal volunteer is chosen, a surgeon will remove part of the person's skull, before a robot dubbed "R1", equipped with cameras, sensors and a needle will push 64 threads into the brain whilst doing its best to avoid blood vessels. Reassuring. Each thread has roughly the diameter of 1/14th of a strand of human hair, and is lined with 16 electrodes that are programmed to gather data about the brain. The electrodes record neural activity related to movement intention, which is then decoded by Neuralink computers. Neuralink did not reveal how many participants would be enrolled in the trial or how many patients the FDA ultimately approved, after a negotiation between the company and agency which raised safety concerns, according to current and former employees. DJ Seo, co-founder and vice president for engineering of Neuralink told Bloomberg: "The short-term goal of the company is to build a generalised brain interface and restore autonomy to those with debilitating neurological conditions and unmet medical needs." "Then, really, the long-term goal is to have this available for billions of people and unlock human potential and go beyond our biological capabilities." Indy100 has reached out to Neuralink for comment. Sign up to our free Indy100 weekly newsletter Have your say in our news democracy. Click the upvote icon at the top of the page to help raise this article through the indy100 rankings. How to join the indy100's free WhatsApp channel

By Viktoriia Lakezina and Max Hunder KHERSON, Ukraine (Reuters) -Hundreds of Ukrainians were rescued from rooftops in the flood-stricken southern

Fans can earn free Twitch drops, including a Charbroiled R99 skin, as they watch the 40 best teams compete in the ALGS Split 2 Playoffs 2023.

Scientists have discovered a way to test whether someone is diabetic by having them speak just a few sentences into their smartphone. A team from US-based Klick Labs created an AI model capable of distinguishing whether a person has Type 2 diabetes from six to 10 seconds of voice audio, with tests revealing an 89 per cent accuracy rate for women and 86 per cent for men. “Our research highlights significant vocal variations between individuals with and without Type 2 diabetes and could transform how the medical community screens for diabetes,” said Jaycee Kaufman, a research scientist at Klick Labs. “Current methods of detection can require a lot of time, travel and cost. Voice technology has the potential to remove these barriers entirely.” The study involved analysing 18,000 recordings in order to identify acoustic features that differentiated non diabetics from diabetics. Using signal processing, they were able to detect subtle changes in pitch and intensity that are imperceptible to the human ear. The tool could prove useful for the estimated 240 million adults around the world who are currently living with the condition without realising, according to figures from the International Diabetes Federation. The latest research demonstrates the ever-growing role AI plays in healthcare, with the convergence of machine learning models, data science helping to improve patient treatment and assisting medical discoveries. The researchers claim the artificial intelligence model, which requires basic health data from the subject in order to determine whether they are diabetic, could be expanded to diagnose other health conditions. “Our research underscores the tremendous potential of voice technology in identifying Type 2 diabetes and other health conditions,” said Yan Fossat, vice president of Klick Labs and leader of the research. “Voice technology could revolutionise healthcare practices as an accessible and affordable digital screening tool.” The technology was detailed in a study, titled ‘Acoustic analysis and prediction of Type 2 Diabetes Mellitus using smartphone-recorded voice segments’, published in the journal Mayo Clinic Proceedings: Digital Health. Read More 10 ways AI will change the world – from curing cancer to wiping out humanity

The US Supreme Court cleared the way for Equitrans Midstream Corp. to resume construction on its controversial Mountain

MEUDON, France--(BUSINESS WIRE)--Aug 30, 2023--

Meta's new Twitter competitor, Threads, has really taken off. And while there's still a slew